IP Library Assignment 068746/0698
Patent Assignment
Reel/Frame 068746/0698

Security Interest

Recorded: 2024-09-30 Pages: 11
Assignors
EMERGENT BIOSOLUTIONS INC.
Executed: 2024-09-30
EMERGENT TRAVEL HEALTH INC.
Executed: 2024-09-30
EMERGENT BIOSOLUTIONS CANADA INC.
Executed: 2024-09-30
Assignee
WELLS FARGO BANK, NATIONAL ASSOCIATION
1800 CENTURY PARK EAST, LOS ANGELES, CALIFORNIA, 90067
Covered Properties (38)
Morphic Forms of Hexadecyloxypropyl-Phosphonate Esters and Methods of Synthesis Thereof
Application: 18/414,198 →
Publication: US 2024/0217938
Formulations of Brincidofovir
Application: 17/872,921 →
Publication: US 2023/0210873
Opioid Antagonist Formulations
Application: 17/919,574 →
Publication: US 2023/0149388
Autoinjector for Administration of Medications
Application: 18/043,996 →
Publication: US 2023/0321354
Stabilized Alkyl Nitrite Compositions
Application: 18/246,982 →
Publication: US 2024/0082198
Hyperimmune Globulin Formulations
Application: 18/246,373 →
Publication: US 2024/0052020
Valiolamine Derivatives as Glucosidase Inhibitors
Application: 18/279,920 →
Publication: US 2024/0174619
Deoxynojirimycin Derivatives as Glucosidase Inhibitors
Application: 18/004,262 →
Publication: US 2025/0197372
Vaccine Compositions
Application: 18/690,650 →
Publication: US 2024/0374709
Autoinjector
Patent: 957,624 →
Application: 29/749,693 →
Autoinjector
Patent: 965,767 →
Application: 29/771,928 →
Compounds, Compositions and Methods for the Treatment of Poxvirus Infections
Patent: 8,642,577 →
Application: 11/401,805 →
Publication: US 2007/0003516
Combinatorial Library Approach to Iminocyclitols with Biological Activity
Patent: 8,445,670 →
Application: 12/382,460 →
Publication: US 2009/0182154
Stable Anthrax Vaccine Formulations
Patent: 8,778,359 →
Application: 13/056,378 →
Publication: US 2011/0229507
Phosphonate Ester Derivatives and Methods of Synthesis Thereof
Patent: 8,569,321 →
Application: 13/223,249 →
Publication: US 2012/0058976
Phosphonate Ester Derivatives and Methods of Synthesis Thereof
Patent: 9,303,051 →
Application: 14/808,388 →
Publication: US 2015/0329575
Compounds, Compositions and Methods for Treating Ocular Conditions
Patent: 8,614,200 →
Application: 13/386,604 →
Publication: US 2012/0165295
2-Pyridone Antimicrobial Compositions
Application: 15/952,616 →
Publication: US 2018/0296555
2-Pyridone Antimicrobial Compositions
Patent: 8,962,842 →
Application: 13/821,250 →
Publication: US 2013/0245035
Antimicrobial 4-Oxoquinolizines
Patent: 9,403,818 →
Application: 13/823,187 →
Publication: US 2013/0252882
Antimicrobial 4-Oxoquinolizines
Application: 15/191,067 →
Publication: US 2017/0232060
Deoxynojirimycin Derivatives and Methods of Their Using
Application: 15/022,005 →
Publication: US 2016/0221993
Temperature Stable Vaccine Formulations
Application: 15/108,244 →
Publication: US 2016/0324957
Iminosugars Useful for the Treatment of Viral Diseases
Application: 15/524,535 →
Publication: US 2018/0273473
Morphic Forms of Hexadecyloxypropyl-Phosphonate Esters and Methods of Synthesis Thereof
Application: 15/828,935 →
Publication: US 2018/0086721
Morphic Forms of Hexadecyloxypropyl-Phosphonate Esters and Methods of Synthesis Thereof
Application: 16/135,171 →
Publication: US 2019/0016687
Morphic Forms of Hexadecyloxypropyl-Phosphonate Esters and Methods of Synthesis Thereof
Application: 16/599,392 →
Publication: US 2020/0095208
Morphic Forms of Hexadecyloxypropyl-Phosphonate Esters and Methods of Synthesis Thereof
Patent: 9,371,344 →
Application: 14/604,334 →
Publication: US 2015/0210724
Morphic Forms of Hexadecyloxypropyl-Phosphonate Esters and Methods of Synthesis Thereof
Patent: 9,862,687 →
Application: 15/160,885 →
Publication: US 2016/0264531
Morphic Forms of Hexadecyloxypropyl-Phosphonate Esters and Methods of Synthesis Thereof
Patent: 8,962,829 →
Application: 14/512,335 →
Antibodies Against Protective Antigen
Patent: 7,601,351 →
Application: 10/602,727 →
Antibodies Against Protective Antigen
Patent: 7,906,119 →
Application: 12/421,139 →
Morphic Forms of Hexadecyloxypropyl-Phosphonate Esters and Methods of Synthesis Thereof
Application: 17/348,831 →
Publication: US 2022/0144782
Adenoviral-Based Vectors
Patent: 8,865,182 →
Application: 12/847,767 →
Publication: US 2011/0123564
Vaccines Against Toxoplasma Gondii
Patent: 9,408,899 →
Application: 13/823,668 →
Publication: US 2013/0273094
ANTIMICROBIAL COMPOSITIONS COMPRISING A HYALURONIC ACID BINDING PEPTIDE AND A beta-LACTAM ANTIBIOTIC
Patent: 9,751,919 →
Application: 14/398,402 →
Publication: US 2015/0218235
Antibodies Against Clostridium Difficile
Application: 14/648,234 →
Publication: US 2015/0290319
Toxoplasma Gondii Vaccines and Their Use
Application: 17/692,333 →
Publication: US 2022/0202921
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 24, 2006
From: ALMOND, MERRICK R.; PAINTER, GEORGE R.
To: CHIMERIX, INC.
Reel/Frame 018163/0459 →
Assignment of Assignor's Interest Oct 24, 2011
From: WARE, ROY W.; ALMOND, MERRICK R.; LAMPERT, BERNHARD M.
To: CHIMERIX, INC.
Reel/Frame 027109/0809 →
Assignment of Assignor's Interest Mar 16, 2012
From: PAINTER, GEORGE R.; ALMOND, MERRICK R.
To: CHIMERIX, INC.
Reel/Frame 027879/0693 →
Assignment of Assignor's Interest May 7, 2013
From: MORIARTY, ROBERT M.; MITAN, CARMEN; PHARES, KENNETH R.
To: UNITED THERAPEUTICS CORPORATION
Reel/Frame 030362/0311 →
Assignment of Assignor's Interest May 28, 2013
From: ROUSSEL, PATRICK; HEIM, JUTTA; SCHNEIDER, PETER; BARTELS, CHRISTIAN
To: EVOLVA SA
Reel/Frame 030494/0894 →
Assignment of Assignor's Interest Jun 3, 2013
From: HEIM, JUTTA; SCHNEIDER, PETER; ROUSSEL, PATRICK; MILLIGAN, DANIEL
To: EVOLVA SA
Reel/Frame 030532/0159 →
Assignment of Assignor's Interest Mar 27, 2014
From: KAISHEVA, ELIZABET
To: EMERGENT BIOSOLUTIONS INC.
Reel/Frame 032541/0595 →
Assignment of Assignor's Interest Jul 27, 2015
From: WARE, ROY W.; LAMPERT, BERNHARD M.; ALMOND, MERRICK R.
To: CHIMERIX, INC.
Reel/Frame 036181/0819 →
Assignment of Assignor's Interest Jul 29, 2015
From: EVOLVA SA
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 036213/0155 →
Assignment of Assignor's Interest Jul 29, 2015
From: EVOLVA SA
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 036213/0139 →
Assignment of Assignor's Interest Oct 23, 2015
From: UNITED THERAPEUTICS CORPORATION
To: UNITHER VIROLOGY, LLC
Reel/Frame 036869/0480 →
Assignment of Assignor's Interest Apr 26, 2017
From: EVOLVA SA
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 042150/0344 →
Assignment of Assignor's Interest Apr 26, 2017
From: HEIM, JUTTA; ROUSSEL, PATRICK; SCHNEIDER, PETER; DALE, GLENN
To: EVOLVA SA
Reel/Frame 042150/0252 →
License Oct 29, 2019
From: CHIMERIX, INC.
To: SYMBIO PHARMACEUTICALS LIMITED
Reel/Frame 050864/0318 →
Assignment of Assignor's Interest Jan 27, 2020
From: EMERGENT VIROLOGY LLC
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 051626/0388 →
Assignment of Assignor's Interest Nov 11, 2020
From: GAETAN, PAINCHAUD; TODESCO, MARC
To: NEMERA LA VERPILLIERE
Reel/Frame 054336/0830 →
Assignment of Assignor's Interest Dec 14, 2020
From: NEMERA LA VERPILLIERE SAS
To: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Reel/Frame 054637/0821 →
Assignment of Assignor's Interest Mar 3, 2021
From: EMERGENT BIOSOLUTIONS OPERATIONS LANSING LLC
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 055471/0900 →
Assignment of Assignor's Interest Apr 12, 2021
From: COURSEY, JOHNATHAN STUART
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 055892/0630 →
Assignment of Assignor's Interest Sep 1, 2021
From: SMITH, KATHY; YEMANE, GIRUM
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 057349/0678 →
Assignment of Assignor's Interest Jul 28, 2022
From: KABIR, MOHAMMED; NADERER, ODIN JOHANN; GROSSI, IRMA MARISA
To: CHIMERIX, INC.
Reel/Frame 060658/0052 →
Assignment of Assignor's Interest Nov 10, 2022
From: CHIMERIX, INC.
To: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Reel/Frame 061720/0982 →
Assignment of Assignor's Interest Dec 4, 2022
From: CHIMERIX, INC.
To: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Reel/Frame 061964/0880 →
Corrective Assignment to Correct the Assignee: Emergent Biodefense Operations Lansing Llc 3500 Martin Luther King Jr. Blvd, Lansing, Michigan 48906 Previously Recorded at Reel: 061720 Frame: 0982. Assignor(S) Hereby Confirms the Assignment. Dec 4, 2022
From: CHIMERIX, INC.
To: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Reel/Frame 062054/0526 →
Change of Name May 5, 2023
From: UNITHER VIROLOGY
To: EMERGENT VIROLOGY LLC
Reel/Frame 063557/0828 →